DefinitionThis section has been translated automatically.
By definition (according to ESCOP = European Scientific Cooperative on Phytotherapy, see below. Phytotherapy), phytotherapeutic drugs are drugs that contain as active ingredients exclusively "plants, plant parts or plant constituents or combinations thereof, in processed or unprocessed state. Phytotherapeutics are therefore mixtures of substances and not individual substances. Their effect results from the sum of their ingredients. A chemical isolation of a single medicinal substance does not take place.
Classical dermatological phytotherapeutics are or were e.g. the different tars (wood tars: Pix betulina, Pix fagi, Pix juniperi, Pix pinaceae or coal tar: Pix lithanthracis or their extracts - LIquor carbonis detergens), ichthyol, podophyllin or the antipsoriatic chrysarobin which is no longer used today.
A number of current drugs are of plant origin, e.g. the cytostatics vincristine, vinblastine, taxol, digitoxin and atropine, but not phytotherapeutics in the strict sense, since only the isolate or its chemical modifications are used medicinally.
Undesirable effectsThis section has been translated automatically.
Note(s)This section has been translated automatically.
- Monographs are prepared e.g. by theCommittee for Herbal Medicinal Products (HMPC), the European Medicines Agency (EMA) and the WHO. Furthermore, collections of material from various associations (e.g. Furthermore, collections of material of different associations (e.g. on European level the Euro-Monographs of the "European Scientific Cooperative on Phytotherapy - ESCOP") are taken into account. In the EU countries, finished herbal medicinal products, like other finished medicinal products, must be officially approved before marketing in accordance with the provisions of pharmaceutical law. For this purpose, quality, efficacy and safety have to be proven.
- The quality of clinical studies is mostly classified according to a "level of evidence, LOE" of A-D.
- A = highest level with randomised, clinically controlled studies and cohort studies
- B = conclusive, retrospective or investigative cohort studies, case-control studies, and follow-up studies from A
- C = case reports or follow-up studies from B
- D = expert opinion without scientific background, pure laboratory research.
- The decision which preparation to prescribe depends on their personal view of disease, disease mechanisms and on the medicinal plants or their active ingredients.
- Selected, dermatologically relevant phytotherapeutics:
- Araroba tree (Goa powder - Chrysarobin)
- Aloe vera
- Balloon vine (Cardiospermum)
- Bittersweet stem (Dulcamara)
- Borage (Borage seed oil)
- Calendula ( marigold)
- Cayenne pepper
- Eucalyptus (Eucalyptus oil)
- Ginkgo biloba
- Ginkgo biloba
- Hamamelis (witchhazel )
- Wood tars (birch wood tar, beech wood tar) / coal tar (see tar below)
- St. John's wort
- Chestnut (horse chestnut)
- Kitchen onion
- Caraway (black cumin - eczema, atopic)
- Larch turpentine (boils, carbuncles)
- Lavender (lavender oil)
- Tree of life (Thuja)
- Lemon balm ( Lemon balm)
- Myrrh (oral aphthae, gingivitis)
- Evening Primrose (Evening Primrose Oil)
- Polypodium leucotomos (Heliocare)
- Rosemary (head itching, dandruff)
- Silver willow (salix alba)
- Licorice root (glycyrrhiza glabra, licorice)
- Tea, green
- Tea, black
- Tea tree (tea tree oil)
- Vine leaves, red
- Wheat (wheat bran).
LiteratureThis section has been translated automatically.
- Arberer W (2008) Contact allergy and medicinal plants. JDDG 6: 15-24
- Mitchell JC et al (1979) Botanical Dermatology. Vancouver, Greengrass